Scientific Corner

The fourth EAN Science School took place in Salzburg, Austria on 21-25 March, bringing together 65 participants from 23 countries.

For the first time, guidelines for the management of urogenital symptoms reported by have been developed specifically for neurologists through a collaboration between the EAN, the International Neuro-Urology Society (INUS) and the European Federation of Autonomic Societies (EFAS).

Join us for an engaging workshop where you will step into the role of a Task Force member tasked with developing an EAN clinical guideline for the use of selective anti-Aβ monoclonal antibodies in treating Alzheimer’s disease.

Our summary of neurological news items the European Medicines Agency (EMA) monthly Human Medicines Newsletter.

Our summary of neurological news items the European Medicines Agency (EMA) monthly Human Medicines Newsletter.

We are pleased to announce two Joint Sessions co-hosted by the EAN at the 33rd European Congress of Psychiatry (Madrid, 5-8 April)

The EAN is delighted to announce the launch of the third cohort of our dedicated guideline education programme – CoCoCare (Cost-Conscious Healthcare) 2025.

Our summary of neurological news items the European Medicines Agency (EMA) monthly Human Medicines Newsletter.

Our summary of neurological news items the European Medicines Agency (EMA) monthly Human Medicines Newsletter.

Our summary of neurological news items the European Medicines Agency (EMA) monthly Human Medicines Newsletter.

The EAN is looking for a candidate who will provide support to the EAN Guideline Production Group and Guideline Taskforces as a Junior Methodologist. Application is open until 29 November.

EBRAINS has announced an open call for proposals aimed at integrating models of the brain's vascular architecture with EBRAIN’s Human Brain Atlas, with the aim of enhancing the usability of brain vasculature data for research and clinical applications, fostering collaboration between institutions and the EBRAINS consortium.

EAN Scientific & Coordinating Panel Members, EAN Individual Members, National Societies, Partner Societies, and Patient Representatives are invited to submit proposal for topics which would benefit from the development of guidelines.

The EAN strongly endorses the newly published EBC perspective paper on Rethinking Alzheimer's Disease given that Alzheimer's disease is a devastating neurological disease affecting more and more people in Europe and across the world due to ageing societies.

The EAN Board and Scientific Committee are pleased to announce the creation of a Neurological Emergency Medicine Task Force, and are now calling for expressions of interest from potential members.